Literature DB >> 2282922

Plasma viscosity, fibrinogen and haematocrit in the course of unstable angina.

J Fuchs1, A Pinhas, E Davidson, Z Rotenberg, J Agmon, I Weinberger.   

Abstract

Plasma viscosity, fibrinogen and haematocrit were measured in 80 patients with unstable angina on the 1st, 2nd and 5th day of hospitalization. In the group of patients who developed acute myocardial infarction (AMI) during hospitalization (20 patients), plasma viscosity was elevated during the entire observation period (1.69 +/- 0.05 cp, normal range 1.38-1.48 cp), while in patients who did not develop AMI, plasma viscosity was only mildly elevated (1.59 +/- 0.05 cp, P less than 0.001 vs the group who developed AMI) and tended to normalize towards the 5th day of hospitalization. Fibrinogen and haematocrit showed similar variations between the two groups. In a group of 20 patients who received heparin, the studied parameters were similar to the group who did not develop AMI. The importance of haemorheological factors in the clinical course of unstable angina is thus emphasized.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2282922     DOI: 10.1093/oxfordjournals.eurheartj.a059630

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  3 in total

Review 1.  Androgens and erythropoiesis: past and present.

Authors:  S Shahani; M Braga-Basaria; M Maggio; S Basaria
Journal:  J Endocrinol Invest       Date:  2009-04-07       Impact factor: 4.256

2.  Rosuvastatin Reduces Blood Viscosity in Patients with Acute Coronary Syndrome.

Authors:  Lae-Young Jung; Sang-Rok Lee; Jin-Mu Jung; Yi-Shik Kim; Sun-Hwa Lee; Kyoung-Suk Rhee; Jei-Keon Chae; Dong-Hwan Lee; Dal-Sik Kim; Won-Ho Kim; Jae-Ki Ko
Journal:  Korean Circ J       Date:  2016-03-21       Impact factor: 3.243

3.  Critical shear stress of red blood cells as a novel integrated biomarker for screening chronic kidney diseases in cases of type 2 diabetes.

Authors:  Il Rae Park; Jimi Choi; Eun Young Ha; Seung Min Chung; Jun Sung Moon; Sehyun Shin; Sin Gon Kim; Kyu Chang Won
Journal:  Clin Hemorheol Microcirc       Date:  2022       Impact factor: 2.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.